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956Objectives: The present study compared the outcomes between combined proximal descending aortic endog-
rafting plus distal bare metal stenting and conventional proximal descending aortic stent-graft repair in patients
with type A and type B aortic dissection.
Methods: From January 2003 to December 2010, 63 patients underwent endovascular treatment for acute (type
A, 24; type B, 21) and chronic (type B, 18) aortic dissection. Of these, 40 patients underwent proximal descend-
ing aortic endografting plus distal bare metal stenting (group 1), and 23 underwent proximal descending stent-
graft repair alone (group 2). All patients with type A dissection underwent open surgical intervention plus
adjunctive retrograde endovascular repair.
Results: The patients were comparable for baseline characteristics and treatment indicators, but more group
1 patients were active smokers (P ¼ .03). The intraoperative characteristics were also similar, although 4 pa-
tients, all in group 2, developed malperfusion syndrome postoperatively (P¼ .02). The overall hospital mortality
was 6%. At a mean follow-up of 49 months, 9 group 2 patients (43%) required unplanned secondary interven-
tion compared with 4 in group 1 (11%; P¼ .007). Reintervention for thoracoabdominal aortic aneurysm or vis-
ceral ischemia was performed in 4 patients (19%) from group 2 (P¼ .03). Late aortic-related deaths occurred in
1 (5%) and 2 (5%) patients in groups 1 and 2, respectively.
Conclusions: Combined proximal descending aortic endografting plus distal bare metal stenting for aortic dis-
section provides favorable short-term outcomes and decreases late distal aortic complications compared with
conventional endovascular repair. These results support a more widespread application of this approach. A pro-
spective, randomized trial is needed before definite conclusions can be made. (J Thorac Cardiovasc Surg
2012;144:956-62)The past decade has seen the evolution of endovascular
prostheses for the treatment of descending aortic dissection.
Initial reports described the use of proximal stent-grafts to
seal primary entry tears in type B dissection,1-3 and
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The Journal of Thoracic and Cardiovascular Surgresults.4-6 The use of stent grafts in type A dissection has
been described in conjunction with open surgical
techniques to address distal aortic complications.7-9 Stent-
grafting the distal dissected aorta aims to decompress the
thoracic false lumen, with resultant thrombosis and
remodeling.
However, even after successful thoracic stent-graft place-
ment, the fate of the distal thoracoabdominal aortic segment
often remains unresolved. Proximal endograft closure can
result in incomplete aortic repair, with the abdominal aorta
failing to remodel in 50% to 80% of cases.4 This risks com-
plications such as malperfusion, aneurysmal degeneration,
and rupture. To achieve more complete aortic reconstruc-
tion, our group developed the novel endovascular treatment
strategy of combined descending aortic endografting plus
distal bare metal stenting to manage aortic dissection,
a technique we termed ‘‘Staged Total Aortic and Branch
vesseL Endovascular reconstruction’’ (STABLE).10-12 The
purpose of the present study was to compare the
outcomes of standard proximal descending aortic stent-
grafting to the more radical STABLE approach in treating
type A and type B aortic dissection.ery c October 2012
Abbreviations and Acronyms
CTA ¼ computed tomography angiography
STABLE ¼ staged total aortic and branch vessel
endovascular reconstruction
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SMATERIALS AND METHODS
A retrospective review of the cardiovascular surgical database at St Vin-
cent’s Hospital, Melbourne, was performed from January 2003 to Decem-
ber 2010. The patients’ medical records were reviewed for the preoperative
patient characteristics, dissection morphology, details of the operative
strategy, intraoperative events, and postoperative course.
From January 2003 to December 2010, 117 patients presented to our ter-
tiary referral center with type A or type B aortic dissection. Of these 117
patients, 63 underwent endovascular treatment for repair of acute (type
A in 24 and type B in 21) and chronic (type B in 18) aortic dissection. These
63 patients were separated into group 1 (n¼ 40; acute type A in 14, chronic
type A in 2, acute type B in 16, and chronic type B in 8), who underwent
STABLE repair, and group 2 (n ¼ 23; acute type A in 6, chronic type A
in 2, acute type B in 10, and chronic type B in 5), who underwent proximal
stent-graft therapy alone as the control group. The type of endovascular re-
pair undertaken was determined by the treating surgeon.
The St Vincent’s Hospital ethics committee approved this retrospective
study and waived the need for individual patient consent. All patients gave
informed consent for each procedure.
Data Collection and Analysis
The data were analyzed using SPSS software, version 20.0 (SPSS Inc,
Chicago, Ill). Student’s t test was used to assess the differences in numeric
variables. Fisher’s exact test was used to assess the differences in categor-
ical values.
Endovascular Prosthesis and Procedure
Baseline computed tomography angiography (CTA)withmultiplanar re-
constructionwas performed to assess the feasibility of the endovascular pro-
cedure, patency of the visceral vessels, choice of peripheral access site, and
sizing of the stent grafts. All patients were treated under general anesthesia.
A detailed description of the Zenith Dissection Endovascular System
(Cook, Inc, Bloomington, Ind) has been previously reported.10-12 The
STABLE procedure involved endograft closure of the proximal entry tear
and distal bare metal Z-stenting. Patients with type A dissection
underwent open surgical intervention, as indicated, plus adjunctive
retrograde proximal endograft deployment with bare metal stenting in
cases in which dissection extended beyond the resected aorta. The extent
of bare metal stenting was determined by the distal extension of the
dissection and any branch vessel or true lumen compromise.
The common femoral artery was used for peripheral access in all pa-
tients. Fluoroscopy and transesophageal echocardiography were used to
guide placement of a guidewire over a pigtail catheter maneuvered in the
true lumen. The Zenith TX2 graft was then advanced and deployed. Aor-
tography and transesophageal echocardiography were subsequently per-
formed to ensure accurate stent-graft placement, and, in cases of type B
dissection, to assess appropriate exclusion of the proximal entry tear.
The delivery systems were exchanged and the Zenith dissection endovas-
cular stent was then advanced and deployed, overlapping 1 stent body
with the proximal stent-graft. Among the group 2 patients, 21 (91%) under-
went treatment with the Cook Zenith TX2 thoracic TAA endovascular graft
(Cook Medical Inc), 1 patient received a Luminexx vascular stent (R Bard
Inc, Murray Hill, NJ), and 1 patient received a Fluency plus vascular stent
graft (Bard, Inc, Tempe, Ariz).The Journal of Thoracic and CaDistal adjunctive procedures were undertaken if secondary entry tears
were identified. The endovascular techniques used included aortic endog-
rafting, covered stent insertion in branch vessels, or embolization using
coils or glue.
Follow-up Imaging
Serial CTA was performed to measure true lumen expansion, aortic
growth, and false lumen perfusion at the latest follow-up CTA.RESULTS
Preoperative and Procedural Characteristics
The preoperative risk factors were similar in groups 1 and
2 (Table 1). However, more group 1 patients were active
smokers (12 vs 1, P ¼ .02). The intraoperative characteris-
tics among the patients with type A dissection were compa-
rable between the 2 groups (Table 1). Predictably, a greater
mean number of devices were deployed in the group 1 pa-
tients than in the group 2 patients (3.1 vs 1.8, P ¼ .001).
In group 1, distal bare metal stent coverage extended to
the infrarenal aorta in 9 (56%) and 16 (67%) patients
with type A and type B dissection, respectively.In-Hospital Outcomes
The postoperative complications did not differ between
the 2 groups (Table 2). The in-hospital incidence of bowel
ischemia or malperfusion was significantly greater in group
2 (n¼ 4, P¼ .01; Table 2). Of these 4 patients, 2 (9%) with
acute type B dissection developed mesenteric ischemia, 1 of
whom also developed limb and spinal cord ischemia and re-
quired a prolonged hospital stay. The other patient devel-
oped hypotension and acidosis soon after leaving the
operating room and died 24 hours later. The remaining 2 pa-
tients required reintervention to treat their bowel malperfu-
sion. One with chronic type B dissection had a prolonged
hospital stay complicated by superior mesenteric artery
and renal artery malperfusion, necessitating additional
stent-graft insertion. Surgical reintervention (right external
iliac artery to superior mesenteric artery bypass) was re-
quired in the other patient with acute type B dissection 8
days after the primary procedure. The hospital mortality
was 5% (2 of 40 patients; acute type A in 1 and acute
type B in 1) in group 1 and 9% (2 of 23 patients; acute
type B in 2) in group 2 (Table 2). One intraoperative death
occurred in each group.Follow-up Outcomes
The mean follow-up was 49 months (range, 5-115).
The overall actuarial survival was 80% in group 1 and
70% in group 2, with 6 late deaths in group 1 and 4 in group
2 (P ¼ .73; Table 3). In group 1, 1 death (3%) was aortic
related, and 5 patients died of unrelated conditions, includ-
ingmyocardial infarction in 2, disseminated carcinoma in 2,
and complications secondary to a fractured femur in 1.
Another patient died 24 hours after pacemaker insertionrdiovascular Surgery c Volume 144, Number 4 957
TABLE 1. Baseline characteristics and preoperative clinical status
Variable
STABLE group
(n ¼ 40)
Control
(n ¼ 23)
P
value
Age (y) 55  13 61  12 .10
Male gender 29 (73) 14 (61) .40
Marfan syndrome 2 (5) 0 .53
Hypertension 30 (75) 21 (91) .18
Hypercholesterolemia 12 (30) 7 (30) 1
Diabetes mellitus 3 (8) 4 (17) .25
Active smoking 12 (30) 1 (4) .02
Previous CVA 2 (5) 1 (4) 1
History of aortic dissection 5 (13) 4 (17) .71
History of AAA 1 (3) 0 1
Previous cardiovascular surgery 9 (23) 5 (22) 1
AVR 1 (3) 1 (4) 1
MVR 2 (5) 0 .53
CABG 2 (5) 1 (4) 1
Type A aortic dissection repair 4 (10) 3 (13) .69
Malperfusion 25 (63) 13 (57) .78
Cardiac 2 (5) 1 (4) 1
Cerebral 3 (8) 2 (9) 1
Visceral(celiac, mesenteric, renal) 16 (40) 9 (39) 1
Iliofemoral 7 (18) 5 (22) .75
Both (visceral and iliofemoral) 2 (5) 0 .53
Data presented as mean SD or n (%). AAA, Abdominal aortic aneurysm; AVR, aor-
tic valve replacement; CABG, coronary artery bypass grafting; CVA, cerebrovascular
accident; MVR, mitral valve replacement; STABLE, staged total aortic and branch
vessel endovascular reconstruction.
TABLE 2. Intraprocedural details and postoperative outcomes
Variable
STABLE group
(n ¼ 40)
Control group
(n ¼ 23)
P
value
Procedural characteristics
Average interval to
intervention (d)
Acute 5.4  4.2 4.9  5.2 .72
Chronic .13
Median 48 56
Range 20-1095 15-388
Devices deployed (n) 3.1  1.7 1.8  1.3 .001
Coverage of left subclavian
artery
5 (13) 6 (26) .30
Supra-aortic branch vessel
involvement (type A)
6 (15) 5 (22) .51
Adjunctive procedures at
primary intervention
Distal stent graft extension 7 (18) 3 (13) .73
Branch vessel covered
stent graft
Renal artery 5 (13) 1 (4) .40
Mesenteric artery 0 1 (4) .36
Iliofemoral vasculature 1 (3) 3 (13) .13
Embolization (coils, glue) 9 (23) 4 (17) .75
Carotid–subclavian bypass 0 2 (9) .12
Access vessel repair 1 (3) 2 (9) .55
Intraprocedural results
Deaths 0 1 (4) .36
Complications 1 (3) 2 (9) .55
In-hospital morbidity
Stroke 2 (5) 1 (4) 1
Bowel
ischemia/malperfusion
0 4 (17) .01
Requiring surgical
intervention
0 1 (4) .36
Transient spinal cord
ischemia
0 1 (4) .36
Limb ischemia 0 2 (9) .12
Acute renal failure 6 (15) 5 (22) .51
Permanent dialysis 0 0 0
Myocardial infarction 2 (5) 0 .53
ICU stay (d) 3.6  6.8 3.7  8.8 .88
Hospital stay (d) 13.6  10.8 13.7  15.6 .58
Mortality
30-d/In-hospital 2 (5) 2 (9) .62
Data presented as mean  SD or n (%). ICU, Intensive care unit; STABLE, staged
total aortic and branch vessel endovascular reconstruction.
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The aortic-related death occurred in a 71-year-old woman
with chronic aneurysmal type B dissection causing visceral
malperfusion. After undergoing STABLE repair, a re-entry
tear remained in the left renal artery, because stent deploy-
ment was not deemed technically possible. She underwent
emergency reintervention 4 weeks later for acute aneurys-
mal expansion of the thoracic aorta. False lumen perfusion
persisted, and she died suddenly 4 months later of aortic
rupture. Among the group 2 patients, late mortality oc-
curred secondary to pancreatic cancer in 1 and respiratory
failure in another. The other 2 late deaths (9%) were aortic
related. One died of abdominal aortic aneurysm rupture 11
months after repair of acute type B dissection. Another died
of multiorgan failure secondary to a ruptured 9.5-cm
abdominal aortic aneurysm 6 years after primary repair of
acute type B dissection.
The requirement for an unplanned secondary reinterven-
tion differed significantly between the 2 cohorts, with 4
of 38 in group 1 versus 9 of 21 in group 2 (P ¼ .007;
Table 3). In group 1, 3 patients (8%; acute type A in 1, acute
type B in 1, and chronic type B in 1) required secondary en-
dovascular reintervention (Table 3). Additional stent-graft
deployment was undertaken to treat proximal stent migra-
tion leading to left subclavian artery dissection in 1, type
1 endoleak in 1, and a retroperitoneal hematoma in 1
patient. Finally, 1 patient in group 1 (3%, acute type B)958 The Journal of Thoracic and Cardiovascular Surgrequired open reoperation after developing proximal endog-
raft infection, leading to aortobronchial fistula formation
(Table 3).
Among the group 2 patients, 7 (33%; acute type A in 1,
acute type B in 5, and chronic type B in 1) underwent un-
planned secondary endovascular reintervention, and 2
(10%; acute type A in 1 and acute type B in 1) required sur-
gical reintervention (Table 3). One patient required covered
stent graft deployment and coil embolization of the rightery c October 2012
TABLE 3. Long-term survival and secondary cardiovascular
interventions
Variable
STABLE group
(n ¼ 38)
Control group
(n ¼ 21)
P
Value
Secondary interventions 4 (11) 9 (43) .007
Surgical 1 (3) 2 (10) .28
Endovascular 3 (8) 7 (33) .03
Late distal aortic
reintervention
0 4 (19) .01
Aneurysmal degeneration 0 3 (14) .04
Visceral ischemia 0 1 (5) .35
Late adverse events
Stroke 1 (3) 2 (10) .28
Permanent dialysis 0 1 (5) .36
Late mortality 6 (16) 4 (19) .73
Data presented as n (%). STABLE, Staged total aortic and branch vessel endovascular
reconstruction.
Hofferberth et al Evolving Technology/Basic Sciencecommon carotid artery to treat a proximal re-entry tear
causing arch growth. The patient recovered uneventfully,
with no evidence of residual dissection. Two patients under-
went extension of the Cook-TX2 stent-graft for type 1 endo-
leak, with one receiving concurrent left subclavian artery
coil embolization. Four (19%; three with acute and one
with chronic type B dissection) required distal aortic
reintervention. One patient received additional branch
graft covered stent-grafting for renal malperfusion, and
three (14%) underwent endograft repair of thoracoabdomi-
nal aortic aneurysms. Of these patients, 1 died of a continu-
ously expanding abdominal aortic aneurysm 13 months
after secondary intervention (Table 2) and 1 experienced
dislocation of the extension stent-graft, necessitating addi-
tional open surgical reintervention. The other surgical rein-
tervention was an aortic root replacement because of severe
aortic regurgitation caused by noncoronary cusp necrosis.E
T
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SAortic Remodeling
Of the 38 survivors in group 1, at least 1 follow-up
CTA (>6 months) was available for 32 patients (84%;
Table 4 and Figure 1). Of the 21 group 2 hospital survivors,
13 (62%) had follow-up CTA scans available (Table 4). In
group 1, the maximal aortic diameters remained stableTABLE 4. Status of false lumen
Complete
false lumen
thrombosis
Partial
false lumen
thrombosis
Fully patent
false lumen
Group 1 (n ¼ 32)
Thoracic 23 (72) 4 (12) 5 (16)
Abdominal 13 (40) 6 (20) 13 (40)
Group 2 (n ¼ 13)
Thoracic 6 (46) 6 (46) 1 (8)
Abdominal 2 (15) 3 (23) 8 (62)
Data presented as n (%).
The Journal of Thoracic and Cafrom baseline to the latest radiologic follow-up examina-
tion (thoracic aorta 42.3  13.3 mm, P ¼ .89; abdominal
aorta 30.4  6.8 mm, P ¼ .88). The true lumen index
(true lumen diameter/total aortic diameter) increased sig-
nificantly in both the thoracic (0.42  0.2 to 0.74  0.2,
P ¼< .001 and abdominal aorta (0.48  0.2 to 0.70 
0.2, P ¼< .001) from baseline to the latest follow-up ex-
amination. In group 2, the maximal aortic diameter in-
creased by more than 5 mm (41.1  11 to 48.9  8 mm,
P ¼ .06) in the thoracic aorta, and the abdominal aorta
displayed significant growth at the latest follow-up exami-
nation (26.9  6.3 to 35.6  15 mm, P ¼ .05). The true
lumen index increased significantly in the thoracic aorta
(0.48 0.1 to 0.65 0.2, P¼ .03); however, no significant
expansion occurred in the abdominal aorta (0.54  0.3 to
0.63  0.30, P ¼ .52) from baseline to the latest follow-
up examination. The false lumen status at the latest
follow-up examination is listed in Table 4.
DISCUSSION
The rationale for endovascular treatment of aortic dissec-
tion has been based on exclusion of the false lumen from the
circulation. Exclusion of the proximal entry tear aims to de-
compress the thoracic false lumen, with resultant thrombo-
sis and induction of aortic remodeling. However, with this
limited approach, the distal thoracoabdominal aspect of
the dissected aorta fails to remodel in 50% to 80% of
cases.4 This is likely because of the presence of multiple
re-entry tears leading to distal communication sites between
the true and false lumens. Furthermore, the flapping motion
of the dissecting lamella prevents induction of complete
false lumen thrombosis in the distal thoracoabdominal
aorta. Incomplete aortic repair using the limited proximal
endograft approach leaves the patient at risk of late compli-
cations, including aneurysmal degeneration, extension of
dissection, distal reoperation, or rupture. Adjunctive stent-
graft deployment to cover distal thoracic re-entry tears
above the celiac trunk might enhance false lumen thrombo-
sis. However, coverage greater than 20 cm leads to an in-
creased risk of spinal cord ischemia.13 Moreover, this
approach does not adequately address distal true lumen col-
lapse and the consequent risk of visceral branch
malperfusion.
To address the late distal aortic complications associated
with incomplete true lumen reconstitution, aneurysmal de-
generation, and ongoing false lumen patency, our group de-
veloped the STABLE technique, a novel approach using
combined descending aortic proximal endografting with
distal bare metal stenting.11,12 Subsequently, a number of
small case series have reported the use of bare metal
stents in the distal thoracoabdominal aorta.14-16 Nienaber
and colleagues16 used adjunctive or staged implantation
of bare metal stents in 12 patients with complicated type
B dissection, reporting favorable short-term results. Inrdiovascular Surgery c Volume 144, Number 4 959
FIGURE 1. Preoperative digital subtraction angiogram of acute type B dissection demonstrating, (A) extensive primary entry tear with proximal aneurysm,
with, (B) true lumen collapse and visceral malperfusion. C, Postoperative 3-dimensional computed tomography angiogram after successful deployment of
thoracic TX2 endograft and bare metal stents in the abdominal aorta and left renal and iliac arteries. D, Three-dimensional computed tomography angiogram
at 8 years of follow-up demonstrating aortic stability with complete false lumen thrombosis of the thoracoabdominal aorta.
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using the same Zenith dissection stent that was used in our
cohort in 11 selected patients with chronic type B dissec-
tion. A clinical success rate of 91% was reported at 12
months, with 0% mortality, stroke, or paraplegia. We re-
cently published the midterm results of our initial case se-
ries using the STABLE technique for type A and type B
aortic dissection.10 The study demonstrated low periproce-
dural morbidity and mortality, with favorable distal aortic
remodeling at 57 months. Initial reports from the single-
arm, multicenter STABLE trial (investigating the use of
proximal TX2 thoracic stent grafts and distal bare metal dis-
section stents) in complicated type B dissection have dem-
onstrated favorable clinical and anatomic outcomes at 1
year of follow-up.17
To our knowledge, the present study is the first to com-
pare the outcomes between standard endovascular repair
and STABLE repair. Our contemporary comparison with
the established proximal descending aortic stent-graft re-
pair technique has confirmed the significantly improved pa-
tient outcomes in the acute and remote phases of the
dissection pathology. The rationale for deployment of the
dissection-specific bare Z-stent is to provide rapid support
and immediate expansion of the aortic true lumen. This
reverses distal true lumen collapse and enhances distal
branch vessel flow, thereby acting against malperfu-
sion.11,14 The results of the present study have
demonstrated that the addition of bare metal scaffolding
in the distal thoracoabdominal aorta significantly reduces960 The Journal of Thoracic and Cardiovascular Surgvisceral malperfusion in the acute phase compared with
standard endovascular repair (n ¼ 0 vs n ¼ 4; P ¼ .02).
Moreover, this was achieved without increasing
periprocedural morbidity or mortality.
Aortic Remodeling
Aortic growth has been identified as a major predictor of
poor long-term prognosis in aortic dissection.18,19 It invites
the risk of aneurysmal degeneration and the subsequent
need for distal reintervention. Studies have shown that
proximal stent grafting reduces aneurysmal degeneration
and enhances the true lumen index in the thoracic aorta20;
however, late expansion of the thoracoabdominal aorta
has been reported.21 The STABLE repair addresses this de-
ficiency by preventing growth of the abdominal aorta and
significantly increasing the true lumen index at midterm
follow-up compared with standard endovascular repair.
The differences in aortic remodeling have been reflected
in the significantly different late clinical outcomes seen in
the 2 cohorts. The standard endovascular repair cohort dis-
played significantly greater rates (19% vs 0%, P ¼ .01) of
late distal aortic reintervention for aneurysm formation or
visceral ischemia. This also accounted for the significantly
greater overall reintervention rate among those who re-
ceived proximal stent-graft repair only.
The achievement of false lumen thrombosis has been es-
tablished as a primary therapeutic goal,5,21-23 with ongoing
false lumen perfusion shown to predict late mortality.22
The limited CTA follow-up prevented a robust method ofery c October 2012
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achieve greater rates of complete thrombosis. Nevertheless,
it is noteworthy that most STABLE patients still exhibited
persistent false lumen perfusion, and this group included
all 4 patients who required late reintervention and the single
patient who died of aortic-related causes. The present study
has shown that both treatment approaches fail to achieve
complete false lumen thrombosis in the abdominal aorta
in most cases. However, in the case of the STABLE repair,
the residual false lumen perfusion has not been associated
with an increasing aortic diameter or a worsening true lu-
men index. We tended to manage residual false lumen per-
fusion conservatively in stable patients. Our impression has
been that a balance can be achieved by careful radiologic
follow-up assessing for changing aortic dimensions to pre-
dict impending complications. This allows tolerance of
residual false lumen perfusion in patients with stable
aortic dimensions, permitting timely intervention, where
necessary.
Study Limitations
Our study had several limitations. It was a retrospective,
nonrandomized, single-institution study. The study popula-
tions were heterogeneous in dissection type, and certain as-
pects of therapy were customized to each patient. It solely
reflects our own efforts to improve the unsatisfactory
long-term results with standard endovascular repair in the
management of aortic dissection. The incomplete CTA
follow-up, particularly among the standard endovascular re-
pair group, was a weakness of our study. We also acknowl-
edge that the more radical STABLE approach exposes those
with uncomplicated dissection to potential procedural-
related risks and greater treatment costs. However, by re-
ducing the late aortic complications seen in these patients,
we have aimed to offset the ongoing cost of treating these
complications. Nonetheless, we believe this is the first study
to compare the results of standard proximal-stent graft re-
pair with the relatively novel STABLE approach. The com-
plete clinical data and significant length of follow-up have
enabled a robust comparison of the 2 techniques, thereby
adding valuable information to previous case series. The
present study has provided a proof of concept for the use
of the STABLE procedure in aortic dissection.
CONCLUSIONS
Combined descending aortic endografting with distal
bare metal stenting prevents malperfusion in the acute
phase and decreases late distal aortic complications com-
pared with conventional endovascular repair in type A
and type B aortic dissection. The STABLE technique repre-
sents a work in progress. With additional refinement of this
technique, the results are likely to improve further and be-
come more universally applicable in the management of
aortic dissection. A multicenter, prospective, randomizedThe Journal of Thoracic and Catrial is warranted to find a definitive answer regarding this
treatment strategy.References
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Dr Charles R. Bridges (Charlotte, NC). I enjoyed your presen-
tation very much. Could you enlighten us slightly about the mech-
anism of the results you observed? Correct me if I am wrong, but
you saw increased overall aortic growth in the proximal group
compared with the STABLE group, but you found enlargement
of the true lumen in the STABLE group compared with the prox-
imal group. Can you help us to understand the mechanics of how
the bare metal stent affects remodeling?
For example, one might propose that the decreased incidence of
malperfusion syndromes relates to the stabilizing aspect of that
bare metal stent in the STABLE group; however, in terms of the
change in the relative aortic dimensions, can you help us to under-
stand the mechanism?
Ms Hofferberth. Thank you for your question. Our experience
has been that the use of adjunctive bare metal stenting provides
a form of supportive scaffolding in the distal aorta, which leads
to stabilization of the intimal flap and protection against aneurys-
mal degeneration. It is our impression that with the bare stent, this
mechanism of intimal expansion and stabilization will lead to the
development of a static column of blood in the proximal false
lumen and thereby assist in aortic remodeling. However, this is
only a hypothesis on our part, because it is difficult to specifically
evaluate this process directly.962 The Journal of Thoracic and Cardiovascular SurgDr Bridges. However, despite that, you found that the true
lumen actually enlarged in the STABLE group.
Ms Hofferberth. Yes, that is correct. After placement of the
proximal endograft in the descending thoracic aorta, the dissec-
tion-specific bare metal stents are deployed distally by way of
the true lumen. Bare metal stenting leads to rapid support and im-
mediate expansion of the true lumen. This reverses true lumen col-
lapse and enhances flow to the distal branch vessels, which helps
prevent malperfusion syndromes.
Dr Bridges. So you think that is occurring at deployment, not
an indication of a lack of stability subsequently?
Ms Hofferberth. Yes, our results indicate that is the case. We
have not presented the data. However, when we considered the
size of the true lumen in the thoracic and abdominal aorta imme-
diately after the STABLE procedure, it was the same size that it
was at 1 year and at the latest follow-up examinations.
Dr Bridges. Thank you.
Dr Tomislav Mihaljevic (Cleveland, Ohio). The results are
very nice, and this is an approach and an evolution. So, from
your current experience, what is the contemporary treatment of
an emergency—patients with a type A aortic dissection showing
up at your institution at 2 o’clock in the morning?
Ms Hofferberth. Thank you for your question. One of the four
cardiothoracic surgeons at our institution adopted the STABLE
approach for all patients with type A and type B aortic dissection.
Patients with type A dissection would receive their proximal open
surgical repair, as indicated, and at the time of decannulating the
femoral artery, we would then proceed with deploying the proxi-
mal graft and the bare metal stent. The adjunctive STABLE repair
would usually be conducted at the primary intervention.
Dr Mihaljevic. In all patients with type A dissection?
Ms Hofferberth. The surgeon and interventional radiologist
who conducted all these cases implemented this approach with
all patients who presented with type A dissection and were
admitted under their care.
Dr Mihaljevic. Thank you.ery c October 2012
